AVITA Medical, Inc. (RCEL)
9.91
-0.15
(-1.49%)
USD |
NASDAQ |
Aug 24, 16:00
9.92
+0.01
(+0.10%)
After-Hours: 20:00
AVITA Medical Total Assets (Quarterly) : 47.78M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 47.78M |
| March 31, 2026 | 51.54M |
| December 31, 2025 | 56.39M |
| September 30, 2025 | 63.73M |
| June 30, 2025 | 58.13M |
| March 31, 2025 | 69.56M |
| December 31, 2024 | 79.71M |
| September 30, 2024 | 81.05M |
| June 30, 2024 | 87.83M |
| March 31, 2024 | 97.38M |
| December 31, 2023 | 111.64M |
| September 30, 2023 | 81.01M |
| Date | Value |
|---|---|
| June 30, 2023 | 86.33M |
| March 31, 2023 | 92.62M |
| December 31, 2022 | 98.26M |
| September 30, 2022 | 99.93M |
| June 30, 2022 | 102.67M |
| March 31, 2022 | 106.49M |
| June 30, 2021 | 125.50M |
| March 31, 2021 | 128.09M |
| December 31, 2020 | 69.30M |
| September 30, 2020 | 75.42M |
| June 30, 2020 | 82.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.577B |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 75.62M |
| Shareholders Equity (Quarterly) | -27.84M |
| Debt to Equity Ratio | -1.742 |
| Current Ratio | 0.4132 |
| Net Debt Paydown Yield | -0.69% |